There was no significant difference between the percentages of CD8+CD314+ T-cells in healthy controls and SLE-patients (98.7 ± 0.6% vs. 98.7 ± 1.3%, n.s.). The gene discussed is KLRK1; the disease is systemic lupus erythematosus.